Market Tracker

09/02 6:05pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

12.27
Data as of Sep 02
 +0.70 / +6.05%
Today’s Change
2.26
Today|||52-Week Range
12.29
+269.69%
Year-to-Date

Today’s Trading

Previous close11.57
Today’s open11.81
Day’s range11.80 - 12.29
Volume10,420,427
Average volume (3 months)8,572,323
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)+1.56%
Earnings growth (this year)-13.19%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book7.32

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-1.47-4.26%
KPTIKaryopharm Therapeut...+0.60+1.67%
LGNDLigand Pharmaceutica...+1.26+2.42%
AVNRAvanir Pharmaceutica...-0.12-1.93%
Data as of 3:59pm ET, 09/02/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$58.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Head-Investor Relations
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts